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HUBUNG KAIT ANTARA KEBERGANTUNGAN NIKOTIN DENGAN 
KEPEKATAN SERUM LEPTIN DAN JUMLAH PENGAMBILAN KALORI 
DALAM KALANGAN PEROKOK LELAKI SIHAT DI KOTA BHARU 
 
ABSTRAK 
Merokok didapati mempunyai perkaitan dengan penurunan berat badan manakala 
berhenti merokok pula mempunyai kaitan dengan peningkatan berat badan. Ianya 
dipercayai berlaku akibat kesan perantaraan nikotin. Pendedahan terhadap nikotin 
melalui asap rokok boleh mempengaruhi penghasilan leptin dalam badan. Peningkatan 
kepekatan hormon leptin dalam badan boleh menurunkan selera makan dan 
mengurangkan jumlah pengambilan makanan. Ia seterusnya menghasilkan hubungan 
berkadar songsang antara kepekatan nikotin dan berat badan. Fungsi leptin sebagai 
pengawal selera dikatakan sebagai penyebab kepada perubahan berat badan dalam 
kalangan perokok. Tujuan kajian ini adalah untuk menentukan hubung kait antara 
kebergantungan nikotin dengan kepekatan serum leptin dan jumlah pengambilan kalori 
dalam kalangan perokok lelaki sihat. 
Kajian keratan rentas ini telah dijalankan di Universiti Sains Malaysia, Kampus 
Kesihatan, Kelantan. Perokok lelaki berumur 20-50 tahun telah dipilih secara terarah. 
Manakala kadar aktiviti merokok telah diukur melalui dua kaedah iaitu analisis nikotin 
dalam rambut dan soal selidik melalui kertas soalan ujian terhadap kebergantungan 
nikotin Fagerstrom. Selain itu, sampel darah para peserta yang berpuasa juga telah 
diambil bagi mengukur kepekatan serum leptin dengan menggunakan kaedah ELISA. 
Manakala jumlah pengambilan kalori harian para peserta turut dikira melalui temu duga 
ingatan pengambilan makanan 24 jam. 
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Seramai 107 peserta telah terlibat dalam kajian ini. Purata umur dan BMI para 
peserta adalah masing-masing 37.0 (9.42) tahun dan 24.59 (4.33) kg/m2. Purata bagi 
kepekatan leptin serum dan aras nikotin dalam rambut dalam setiap kumpulan 
kebergantungan nikotin rendah, sederhana dan tinggi adalah tidak berbeza secara 
signifikan. Terdapat korelasi berkadar songsang antara markah Fagerstrom dengan 
kepekatan leptin serum (r=-0.198, p=0.048). Manakala tiada korelasi yang signifikan 
antara aras nikotin dalam rambut dengan kepekatan leptin serum. Purata bagi jumlah 
pengambilan kalori dalam kumpulan kebergantungan nikotin rendah, sederhana dan 
tinggi adalah berbeza secara signifikan (F(2,46)=3.688, p=0.03).Walau bagaimanapun, 
tiada korelasi yang signifikan antara markah Fagerstrom dengan jumlah pengambilan 
kalori. 
Kajian ini menunjukkan terdapat korelasi berkadar songsang antara kepekatan 
leptin serum dengan markah Fagerstrom. Selain itu, terdapat juga perbezaan yang 
signifikan antara purata jumlah pengambilan kalori antara tiga kumpulan yang berlainan 
kadar kebergantungan nikotin. Kumpulan yang mempunyai kadar kebergantungan 
nikotin tinggi mempunyai purata jumlah pengambilan kalori yang paling tinggi 
berbanding dengan kumpulan lain. 
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THE RELATIONSHIP OF NICOTINE DEPENDENCE WITH SERUM LEPTIN 
CONCENTRATION AND TOTAL CALORIE INTAKE AMONG HEALTHY 
MALE SMOKERS IN KOTA BHARU 
ABSTRACT 
 
Cigarette smoking has been demonstrated to be associated with lower body weight and 
its cessation leads to weight gain. This action of smoking on body weight is believed to 
be nicotine mediated. Exposure to nicotine via tobacco smoking may disrupt leptin 
release and decrease feeding by increasing leptin concentration, thereby contributing to 
the inverse relationship between nicotine and body weight. The role of leptin as an 
appetite suppressor is believed to be responsible for weight changes among smokers. 
The aim of this study was to determine the association between nicotine dependence 
with serum leptin concentration and total calorie intake among healthy male smokers.  
This cross-sectional study was conducted in Universiti Sains Malaysia, Health 
Campus, Kelantan. Male smokers aged 20–50 years were purposively recruited. 
Smoking activity was measured by two methods which are through hair nicotine 
analysis and Fagerstrom Test for Nicotine Dependence (FTND) Questionnaire. Smokers 
were divided into low, moderate and high dependence according to Fagerstrom score. 
Fasting blood samples were collected from the subject and serum leptin concentration 
was measured by ELISA (a solid-phase two-site enzyme immunoassay). The total 
calorie intake of the subjects was assessed by 24-hour diet recall interview. 
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A total of 107 subjects were enrolled. The mean age and BMI of the subjects 
were 37.00 (9.42) years and 24.59 (4.33) kg/m², respectively. The mean concentration of 
serum leptin and mean level of hair nicotine among low, moderate and highly nicotine 
dependent groups were not significantly different. There was a significant inverse 
correlation between the Fagerstrom score and serum leptin concentration (r=-0.198, 
p=0.048). However, there was no significant correlation between hair nicotine level and 
serum leptin concentration. The mean of total calorie intake among low, moderate and 
highly smoking dependence groups were significantly different (F(2,46)=3.688, p=0.03). 
However, there was no significant correlation between Fagerstrom score and hair 
nicotine level with total calorie intake. 
The present study showed that serum leptin concentration has a significant 
inverse correlation with Fagerstrome score. There was also a significant difference in the 
mean of total calorie intake between three groups of nicotine dependent where the highly 
dependent groups has the highest total calorie intake. 
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CHAPTER 1  
INTRODUCTION 
 
Cigarette smoking is a leading preventable cause of death and disability, causing 
illnesses including cancer and cardiovascular diseases (WHO, 2011b). It is estimated 
that there are more than 1.3 billion smokers globally and this number is expected to 
increase to 1.6 billion by 2025 (Jha, 2012). Based on the data from the 2008-2010 
Global Adult Tobacco Survey for adults aged 15 years and older, it indicated that the 
proportion of adult men smoker ranges from about 20.0% in Brazil, and to over 60.0% 
in Russia (Jha, 2012). While among adult women, the proportion of smokers ranged 
from 0.5% in Egypt to 24.0% in Poland (Jha, 2012). The number of global death due to 
smoking related diseases is expected to reach 8.3 million by 2030, up from 5.4 million in 
2005 and 6.4 million in 2015 (Mathers and Loncar, 2006; Alwan, 2010). 
 
Most Asian countries confronted this epidemic as well. Multi-country reports and 
reviews showed the prevalence of smoking among adult males ranged from 24.3% in 
India (WHO, 2010b) to 52.9% in China (WHO, 2010a). The prevalence of smoking 
among adult males in other Asian countries were 43.3% in Bangladesh (WHO, 2009a), 
45.6% in Thailand (WHO, 2009b) and 47.7% in the Philippines (WHO, 2010c). These 
variations may be due to differences in the tobacco control initiative and legislation 
implemented in those countries (WHO, 2011b).  
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As for Malaysia, the prevalence of smoking especially among adult male is still 
high in spite of several campaigns over the past decade. According to the report of the 
second and third National Health and Morbidity Surveys in 1996 and 2006, respectively, 
there was only 2.7% reduction in smoking prevalence among males aged 18 years and 
older which decreased from 49.2% to 46.5% (Lim et al., 2013). In addition, the Global 
Adult Tobacco Survey (GATS) 2011 showed the prevalence of Malaysian men who 
currently smoke tobacco which was 43.9% (WHO, 2011a). 
 
One of the main concerns among smoking cessation advocators are the body weight 
changes among smokers. Cigarette smoking has been demonstrated to be associated with 
lower body weight and its cessation leads to weight gain particularly in the first several 
weeks after quitting (Perkins, 1993; Pisinger and Jorgensen, 2007). An inverse 
relationship between nicotine and body weight exists that supports these concern, where 
body weight tends to be lower among moderate and heavy smokers as compared to non-
smokers (Klesges et al., 1991). This action of smoking on body weight appears to be 
nicotine mediated as indicated by Chen et al.(2004). However, it is also believed that the 
influence of cigarette smoking on food intake and to a lesser extent energy expenditure 
account for these weight influences, but specific mechanism by which smoking affect 
energy balance are not completely clear (Perkins, 1993). On the other hand, other 
researcher speculate that there was a clustering factors involved in smoking and body 
weight relationship (Chiolero et al., 2008). The consumption of cigarette smoke, low 
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physical activity and unhealthy diet will contribute to lower body weight as shown in 
Figure1.1. 
 
Figure  1.1 Hypothetical factor linking smoking and body weight (Chiolero et al. 
2008) 
 
Previous studies in animals have reported that nicotine administration decreases 
body weight and caloric intake (Chen et al., 2004; Bellinger et al., 2009; Bura et al., 
2010). On the other hand, chronic smoking has also been reported to modify body 
weight by decreasing the appetite and increasing metabolic rate through an enhancement 
of lipid metabolism. It has been suggested that nicotine might act directly on the 
hypothalamus which is important in the regulation of feeding and energy expenditure 
(Frankish et al., 1995).  
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Furthermore, there were other postulations which explained the effect of smoking on 
body weight. Leptin hormone may be candidate mechanism that contributes to the 
inverse nicotine-body weight relationship (Oeser et al., 1999; Miyata and Meguid, 
2000). The leptin acts as a signaling molecule that communicates the level of adipose 
stores in the body to the hypothalamus, thus acting centrally to regulate metabolic 
activity and body weight (Himms-Hagen, 1999). Exposure to nicotine via tobacco 
smoking may disrupt leptin release, thereby contributing to the inverse relationship 
between nicotine and body weight. Nicotine as an appetite suppressant may decrease 
feeding by increasing leptin level or by enhancing steps along the leptin-receptor-
mediated signaling cascade. Several studies have attempted to test these hypotheses and 
all of them found that nicotine induced changes in leptin concentration (Jo et al., 2005).  
 
Nevertheless, among the few human and animal studies that have examined the 
effects of nicotine and leptin levels among smokers results are inconclusive (Eliasson 
and Smith, 1999; Miyata and Meguid, 2000). In light of these inconsistent findings, the 
present study was conducted to investigate the relationship of nicotine dependence with 
serum leptin concentration and total calorie intake among healthy male smokers. 
 
The present study looked at local data in studying the effect of nicotine dependence 
and nicotine level on serum leptin concentration and total calorie intake among smokers. 
A largely available data in literature have reported different results regarding the 
concentration of leptin hormone among smokers. Some studies found that the 
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concentration is increased while other studies found that it has decreased. On the other 
hand, there were studies which reported that leptin concentration was not affected by 
smoking. Therefore, a study that investigate the exact result of smoking and nicotine 
effect on leptin concentration is necessary by controlling the factors that might interfere 
the results such as age, gender, race, health status and physical activity. 
 
On the other hand, the previous studies were not looking into nicotine dependence 
and nicotine level. There were only two groups involved which are smokers and non-
smokers. Dependency and nicotine level might be a factor which affects the final result 
of leptin concentration. Minimal dependence and low nicotine level could be the answer 
why leptin concentration was not affected by smoking as reported in some studies. The 
effect of smoking on leptin concentration must be studied on different group of smokers 
regarding their dependency and nicotine level to ensure the exact results is obtained. 
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1.1   OBJECTIVES OF THE STUDY 
 
1.1.1   General Objective 
To study the relationship of nicotine dependence with serum leptin concentration and 
total calorie intake among healthy male smokers in Kota Bharu. 
 
1.1.2   Specific Objectives 
1 To determine the concentration of serum leptin among low, moderate and high 
nicotine dependence group in healthy male smokers. 
2 To determine the level of hair nicotine among low, moderate and high nicotine 
dependence group in healthy male smokers. 
3 To determine the total calorie intake among low, moderate and high nicotine 
dependence group in healthy male smokers. 
4 To determine the relationship between hair nicotine level and serum leptin 
concentration in healthy male smokers. 
5 To determine the relationship between hair nicotine level and total calorie intake in 
healthy male smoker. 
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1.2   RESEARCH HYPOTHESES 
1 The concentration of serum leptin is high in highly nicotine dependence smokers 
compared to moderate and low nicotine dependent smokers. 
2 The level of hair nicotine is high in highly nicotine dependence smokers compared to 
moderate and low nicotine dependent smokers. 
3 The total calorie intake is high in low nicotine dependence smokers compared to 
moderate and high nicotine dependence. 
4 High hair nicotine level is associated with high concentration of serum leptin in 
smoker 
5 High hair nicotine level is associated with lower total calorie intake in smokers. 
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1.3   DEFINITION OF TERMS 
 
1.3.1   Leptin 
Leptin is a hormone that plays a key role in regulating energy intake and energy 
expenditure include appetite and metabolism. It works by inhibiting the activity of 
neurons that contain neuropeptide Y (NPY) and agouti-related peptide (AgRP) and by 
increasing the activity of neurons expressing α-melanocyte-stimulating hormone (α-
MSH). The elevation of leptin hormone reduces appetite and food intake (Dardeno et al., 
2010) 
 
1.3.2   Nicotine 
Nicotine is an alkaloid derived from the tobacco plant. It is a substance in tobacco to 
which smokers can become addicted. It also provides pleasure, more less irrespective of 
the behavioral context. It can induce muscular relaxation, suppressing appetite and body 
weight, enhancing learning, memory and sustain mental concentration (United Nation 
Office of drug Control and Crime Prevention Studies, 2000). 
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1.3.3   Nicotine dependence 
Nicotine dependence is defined as a compulsive behavior to consume nicotine on a 
continuous or periodic basis in order to experience its psychic effect and to avoid 
discomfort of its absence (WHO, 1993). According to the 4th edition of Diagnostic and 
Statistical Manual of Mental Disorder (DSM-IV), nicotine dependence is classified 
under substance dependence and diagnosed when the smoker manifested at least three of 
the following criteria within the same 12 months period: 
1. Development of tolerance : 
- a need for markedly increased amounts of the substance to achieve 
intoxication or desired effect. 
- markedly diminished effect with continued use of the same amount of the 
substance. 
2. Withdrawal symptoms : 
- the characteristic withdrawal syndrome for the substance. 
- the same substance is taken to relieve or avoid withdrawal symptom. 
3. Substance use is longer or is in larger quantities than intended. 
4. Permanent wish or failure to control substance use. 
5. Time-consuming procurement, use and recovery from substance. 
6. Important social, professional or recreational activities are given up or limited 
due to substance use. 
7. Continued substance use despite physical or psychic problems. 
(American Psychiatric Association, 2013) 
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1.3.4   Ever Smokers 
Ever smoker is a person who has smoked at least 100 cigarettes in his lifetime. Ever 
smoker can be a currently daily smoker, reducer or ex-smoker:  
 Daily smoker is a person who smokes any tobacco product at least once a day.  
 Reducer is a person who used to smoke daily but now does no longer smoke 
every day. 
 Ex-smoker is a person who was formerly a daily smoker but currently does not 
smoke at all. 
(WHO, 2008b) 
1.3.5 Current smoker 
Adult who have smoked 100 cigarette in their lifetime and currently smoke cigarette 
everyday or some days (nondaily). 
(Centers for Disease Control and Prevention, 2009) 
1.3.6 Smoker (in term of hair nicotine level) 
Smoker who has level of hair nicotine more than 2.77 ng/mg. 
(Kim et al,. 2014) 
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CHAPTER 2  
LITERATURE REVIEW 
 
2.1   NICOTINE 
Nicotine is a natural compound called alkaloid, which is the major psychoactive 
substance in tobacco. It has been found that nicotine has both stimulant and relaxing 
effects. It alters certain hormone in human body and increased the capacity to focus on 
attention. In other words, it reduces anxiety and irritability (United Nation Office of drug 
Control and Crime Prevention Studies, 2000). 
 
Nicotine is also known as a key neuroregulatory component in cigarette smoke. 
It has been suggested that nicotine might act directly on the hypothalamus which is 
important in the regulation of feeding and energy expenditure (Frankish et al., 1995). 
Nicotine as an appetite suppressant may decrease feeding by increasing leptin level or by 
enhancing steps along the leptin-receptor-mediated signaling cascade. Several studies 
have attempted to test these hypotheses and overall of it appear that nicotine induced 
changes in leptin levels (Jo et al., 2005). Nicotine also stimulates the dopaminergic 
pathways of the mesolimbic system in the brain, an area that involved in reinforcement 
for the drug abuse (Tuesta et al., 2011). 
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2.1.1   Absorption of nicotine 
Nicotine is entered into human body through different ways including inhalation of 
cigarette smoke, chewing tobacco, oral snuff and nicotine gum will result in different 
total absorption (Benowitz et al., 2009). However, researchers had also found that 
inhalation of nicotine in the form of smoke provides the quickest delivery (Benowitz, 
1996b; Matta et al., 2007) with nicotine reaching the brain approximately in 7 seconds 
(Stephen A. Maisto et al., 2010). 
 
Nicotine absorption took place in a few parts of the body include in the mouth 
and inside the lung (Benowitz et al., 2009). However, its absorption across biological 
membranes depends on pH. Nicotine is a weak base with a pKa of 8.0 (Benowitz et al., 
2009). Nicotine does not rapidly cross membranes in its ionised state such as in acidic 
environment. In the mouth, only small amount nicotine from cigarette smoke is absorbed 
(Gori et al., 1986). This is due to the pH of smoke from flue-cure tobaccos which is 
found in most cigarettes which is acidic (pH 5.5-6.0) as nicotine is ionised at this pH. In 
contrary, nicotine from air-cured tobaccos which is available in most of tobacco used 
like in pipes, cigars and some other cigarettes, is well absorbed due to it alkaline (pH 
6.5) property and nicotine which is unionised at this pH (Armitage et al., 1978).  
 
However, when cigarette smoke reaches the lung, nicotine is quickly absorbed. 
Dissolution of nicotine in the fluid at pH 7.4 in the lung facilitates nicotine transfer 
13 
 
across membranes (Benowitz et al., 2009). In addition, nicotine concentration in the 
blood circulation also rises rapidly during a smoke and peaks at the completion of 
smoking due to the large surface area of the alveoli and small airways (Benowitz, 1990). 
High levels of nicotine can reach the brain approximately within 10-20 second after a 
puff. This is faster than intravenous administration and could produce a rapid behavioral 
reinforcement (Benowitz, 1990). Therefore, the rapid rise of nicotine level permits the 
smoker to titrate the level of nicotine and related effects during smoking. This also 
makes smoking to be considered as the most reinforcing and dependence producing 
form of nicotine administration (Henningfield and Keenan, 1993). 
 
In addition, a smoker also can manipulate the dose of nicotine and brain nicotine 
levels on a puff-by-puff as the intake of nicotine during smoking depends on puff 
volume, depth of inhalation, the extent of dilution with room air and the rate and 
intensity of puffing (U.S Department of Health and Human Service, 2001). In this 
regard, a machine-determined nicotine yield of cigarettes is not an accurate tool to 
estimate the dose of nicotine by a smoker because of this reason (Jarvis et al., 2001). In 
order to gain more nicotine, cigarette smoker will change their smoking pattern which is 
switching from a higher to a lower yield cigarette for compensation (USDHHS, 2001). 
 
Chewing tobacco and snuff are buffered to alkaline pH in order to facilitate 
absorption of nicotine through oral mucosa. Although absorption through cell 
membranes is rapid for these more alkaline tobacco products, the rise in the brain 
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nicotine level is slower when compared with smoking. Concentration of nicotine in the 
blood rises gradually with the use of smokeless tobacco and plateau at about 30 minutes 
with the levels persisting and declining slowly over 2 hours or more (Benowitz et al., 
1988). 
Absorption of nicotine from most of nicotine replacement therapy (NRT) such as 
nicotine gum, transdermal patch, nasal spray, inhaler, sublingual tablets and lozenges, 
are also slower than smoking (West et al., 2000). Only nasal spray provides a rapid 
delivery of nicotine that is closer to the rate of nicotine delivery achieved with smoking 
(Gourlay and Benowitz, 1997; Guthrie et al., 1999). The absolute dose of nicotine 
absorbed from  nicotine gum is much less than the nicotine content of the gum. This is 
because nicotine is swallowed with subsequent first-pass metabolism (Benowitz et al., 
1987). Some nicotine is also retained in chewed gum. The bioavailabilities for these 
products are mainly contributed by absorption through mucosa of the oral cavity where 
50-80% of the nicotine is swallowed and metabolised. 
 
Nicotine base is well absorbed through skin. This contributes to the occupational 
risk of nicotine poisoning (green tobacco sickness) in tobacco harvesters who are 
exposed to wet tobacco leaves (McBride et al., 1998). Transdermal delivery technology 
is essentially based on this phenomenon. Nicotine patch is one of product that used this 
transdermal delivery technology. It is commonly used as an aid in nicotine replacement 
therapy (NRT) and effective for quitting smoking (Fiore et al., 1994). The rate of release 
of nicotine into skin is depend on the permeability of the skin, rate of diffusion through a 
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polymer matrix and the rate of passage through a membrane in the patches. Therefore, 
rates of nicotine delivery and plasma nicotine concentrations are vary among different 
transdermal systems (Fant et al., 2000). In all cases, there is an initial lag time of about 1 
hour before nicotine appears in the bloodstream and there is a continued systemic 
absorption (about 10% of the total dose) after the patch is removed, the latter due to 
residual nicotine in the skin (Fant et al., 2000). 
 
2.1.2   Distribution of nicotine in body tissues 
About 69.0% ionised and 31.0% unionised nicotine enters the bloodstream at pH 7.4 
after absorption. Binding to plasma proteins is less than 5% (Benowitz et al., 1982). A 
steady-state volume of nicotine averaging 2.6 L/kg is distributed extensively to body 
tissues. Based on human autopsy samples from smokers, the highest affinity for nicotine 
is in the liver, kidney, spleen and lung and the lowest is in adipose tissue. In the skeletal 
muscle, concentration of nicotine and cotinine are close to that of whole blood. Nicotine 
also strongly bound to brain tissues and the receptor binding capacity is increased due to 
a higher number of nicotinic cholinergic receptors in the brain of the smokers (Perry et 
al., 1984; Breese et al., 1997). Nicotine also accumulates in gastric juice and saliva due 
to its ion-trapping capability (Lindell et al., 1996). There is also an evidence that 
nicotine also accumulates in breast milk (Dahlstrom et al., 1990), fetal serum and 
amnionic fluid (Dempsey and Benowitz, 2001).  
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The route and rate of dosing of nicotine will determine the time course of 
nicotine accumulation in the brain and other body organs and the resultant 
pharmacologic effect. Smoking a cigarette delivers nicotine rapidly to the pulmonary 
venous circulation, from which it moves quickly to the left ventricle of the heart and to 
the systemic arterial circulation and brain. The lag time between a puff of a cigarette and 
nicotine reaching the brain is 7 seconds (Stephen A. Maisto et al., 2010). 
 
2.1.3   Biomarker for nicotine exposure 
Nicotine is metabolized to a number of metabolites in the liver including cotinine, 
nicotine N’-oxide, N-isomethonium ion, nicotine glucuronide, 4-oxo-4-(3-pyridyl)-
butanoic acid and nornicotine. Notably, it is about 70.0% to 80.0% of nicotine is being 
converted to cotinine. This made it the highest amount of nicotine metabolite in human’s 
body (Benowitz, 2009). 
 
Nicotine and cotinine are the most common alkaloid being measured as a 
biomarker for nicotine exposure. Cotinine has been used as a biomarker for daily intake, 
both in cigarette smokers and in those exposed to second tobacco smoke because of its 
long half-life (Benowitz, 1996a). The presence of cotinine in biological fluids such as 
plasma, saliva and urine indicates exposure to nicotine (Benowitz, 1996a). Although 
there is a high correlation between steady state cotinine and nicotine intake, there are 
few individual variabilities that might influence the result including the difference 
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conversion percentages of nicotine to cotinine (usually range between 50% to 90%) and 
difference in cotinine metabolism rates (usual clearance range 20-75 ml min-1) 
(Benowitz, 1996a). A limitation of measuring cotinine and nicotine from latter matrices 
as a marker for nicotine exposure is that it only reflects the short-term exposure to 
tobacco and not for chronic exposure because of its average half-life is 16 hours which is 
relatively short (Benowitz, 2009). 
 
When measuring the long-term exposure to smoking, the most recommended 
way is to measure the nicotine by using hair or nails sample compared to other matrices 
(Al-Delaimy, 2002). This is because nicotine is incorporated into hair and nail as it grow 
over time. The average rate of hair growth is 1 cm per month while nails grow at a rate 
of 0.1 cm per month. Thus, measurement of nicotine level in hair and nails are a 
promising biomarker for long-term tobacco exposure similar to the measurement 
involving chronic smokers (Al-Delamy, 2002; Florescu et al., 2007). 
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2.2   HAIR NICOTINE LEVEL MEASUREMENT 
Hair nicotine level measurement has been proposed as one of the methods to determine 
the smoking exposure among smokers (Al-Delaimy, 2002; Appenzeller et al., 2012). 
Assessment based on cigarettes per day might be inaccurate indicators for cigarette 
smoke exposure because of the differences in how smokers smoke their cigarettes and 
the brand of cigarettes itself (Patrick et al., 1994; Al-Delaimy et al., 2000; USDHHS, 
2001). On the other hand, the hair has the capacity in providing more accurate long term 
information on an individual’s exposure to cigarette smoke compared to other biological 
matrices (Al-Delaimy et al., 2002; Appenzeller et al., 2012). The usefulness of nicotine 
concentration in body fluids like in urine, saliva and blood serum, is restricted by the 
short half-life of these biomarkers. The half-life of nicotine in body fluid is 
approximately 2-3 hours (Jaakkola and Jaakkola, 1997). Other advantages of hair as a 
sample matrix include the non-invasiveness of its collection, easy to store and stable 
(Al-Delaimy, 2002; Appenzeller et al., 2012). The nicotine compound in hair is not lost 
by storage of samples for a period of up to five years (Zahlsen and Nilsen, 1994). 
 
It is known that hair at the scalp grows about 1 cm for one month (Myers and 
Hamilton, 1951; Zahlsen and Nilsen, 1990; Harkey, 1993; LeBeau et al., 2011). Its 
growth is considered as the most uniform and faster than other hair in other parts of the 
body such as axillary and pubic. It is also noted that about 85-90% of scalp hair grows 
continuously (Harkey, 1993). Therefore, hair at the scalp is considered as the best site 
for sample collection. The continuous growth and minimum non-growing of hair scalp 
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can provide updated information on exposure to any related substances include nicotine 
(Al-Deilamy, 2002). In addition, the use of this method could avoid bias such as under 
reporting and lack of awareness of exposure usually faced during answering the 
questionnaire (Al-Delaimy, 2002). 
 
Historically, the presence of nicotine in human hairs was first discovered by 
Ishiyama et al., (1983) and further evidenced by other group of researchers from 
different countries (Mizuno et al., 1993; Eliopoulus et al., 1996; Al-Delaimy et al., 
2000; Kim et al., 2008). The result from this measurement also had been further 
compared with a number of cigarettes per day in previous studies in order to show its 
usefulness and reliability in providing information on smoking exposure (Mizuno et al., 
1993; Eliopoulus et al., 1996; Al-Delaimy et al., 2000; Kim et al., 2008). Hair nicotine 
can be analysed by using the radioimmunoassay (RIA) (Haley and Hoffman, 1985), gas 
or liquid chromatography method. Gas and liquid chromatography are the preferred 
analysis method since it provides more accuracy and cost-effective compared to RIA 
(Zahlsen and Nilsen, 1994; Chetiyanukornkul et al., 2004; Kim et al., 2008; Man et al., 
2009). 
 
However, there is a potential problem with the use of hair as a biomarker 
includes a strong influence of hair pigmentation on nicotine binding and uptake where 
the nicotine is bound to melanin. This means a dark hair binds much more nicotine than 
does blonde and white hair (Dehn et al., 2001). In addition, hair also is exposed to 
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nicotine from sweat, sebaceous gland secretion and nicotine from environmental tobacco 
smoke exposure. Therefore, washing the hair before analysis may reduce this 
environment contamination problem (Al-Delaimy, 2002). Apart from that, racial and 
ethnic difference also had influence on nicotine level in human hair. For example, Black 
smokers were found to have a higher hair nicotine level compared to White smokers 
with the same smoking exposure (Apelberg et al., 2011).  
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2.3   LEPTIN 
Leptin is a 16-kDa hormone, originated from the ob (obese) gene. It has been discovered 
and cloned in 1994. It is synthesised and secreted specifically from white adipose cells 
(Zhang et al., 1994). Leptin has multiple central and peripheral actions in regulation of 
energy balance and metabolism, feeding behavior, fertility, and bone metabolism. These 
actions are mediated by specific cell surface leptin receptors (Schwartz et al., 1996; 
Margetic et al., 2002). The leptin receptor (LR), which possesses only one transmbrane 
domain, is known to be presented in the choroids plexus, cerebral cortex, hippocampus, 
thalamus, and hypothalamus (Tartaglia et al., 1995).  The Ob(Lep) gene (Ob for obese, 
Lep for leptin) is located on chromosome 7 in humans. Leptin interacts with six types of 
leptin receptors isoform which are ObRa, ObRb, ObRc, ObRd, ObRe, and ObRf (Lee et 
al., 1996). These isoforms classified to two groups which are short and long leptin 
receptor isoform. The short leptin receptor isofrom ObRa and ObRc are responsible for 
transporting leptin across the blood-brain barrier while the long leptin receptor isoform 
ObRb plays it role in leptin signaling (Dardeno et al., 2010). This ObRb leptin receptor 
is expressed in a variety of organs primarily in the hypothalamus, where it regulate 
energy homeostasis and neuroendocrine function (Dardeno et al., 2010).  
 
Leptin secretion can be promoted by few conditions including excess energy 
stored as fat, overfeeding, the present of glucose, insulin, glucocorticoids, estrogens and 
inflammatory cytokines (Dardeno et al., 2010). Leptin secretion can be inhibited by few 
factor including low energy states with decreased fat stored (leanness), fasting, 
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catecholamines and adrenergic agonists, thyroid hormones and androgens (Dardeno et 
al., 2010). 
Apart from being a biomarker for body fat, serum leptin levels also reflect 
individuals energy balance (Friedman and Halaas, 1998). Multiple studies have shown 
that fasting or following a very low caloric diet (VLCD) lower the leptin levels (Weigle 
et al., 1997; HALUZÃ KOVÃ et al., 2006; Morel et al., 2011). It might be that on 
short term, leptin is an indicator of energy balance (Lin et al., 2001). Additionally, other 
researchers have proposed that the fluctuation of leptin hormone is more sensitive to 
starvation than to overfeeding (Ahima et al., 1996). For example, the leptin levels do not 
rise extensively after over feeding (Romon et al., 1999). It might be that the dynamic of 
leptin due to an acute change in energy balance are related to appetite and eventually to 
food intake (Lin et al., 2001). 
 
Leptin binds to the ventromedial nucleus of the hypothalamus, known as the 
“appetite center”. Thus, circulating leptin levels give the brain input regarding energy 
storage so it can regulate appetite and metabolism. 
 
2.3.1   Leptin and dietary intake 
Researchers have proposed that the level of leptin hormone can be influenced by various 
factors including dietary intake (Koutsari et al., 2003, Murakami et al., 2007). The level 
of leptin has been observed to be higher among healthy postmenopausal women after the 
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consumption of high-carbohydrate and high-sugar diet (Koutsari et al., 2003). In other 
studies, Murakami et al. (2007) found the same result where the intake of dietary fiber 
increased serum leptin concentration among young Japanese women. The results showed 
the increasing of dietary fiber was associated with lower serum leptin concentration 
independent of potential confounding factors, including body mass index. In contrary, 
the level of circulating leptin is reduced among obese subjects in response to energy-
restrictive diets as a consequence of body weight loss (Considine et al., 1996). 
 
2.3.2   Leptin and physical activity 
Apart from the influence of dietary intake, researches have proposed that the level of 
circulating leptin is also influenced by physical activities. It has been proved by some 
researchers that both of short and long-term exercises have shown reduction or no 
change in leptin concentration (Koutsari et al., 2003). Study showed the addition of 
daily moderate intensity exercise among postmenopausal women suppressed both 
fasting and postprandial plasma leptin (Koutsari et al., 2003). This finding has been 
supported by the later study based on mildly obese women and men who underwent a 
supervised diet and exercise intervention. Both of women and men subjects showed a 
significant decreased in serum leptin level (Volpe et al., 2008). Recently, Azizi (2011) 
found a lower serum leptin level among un-trained females after underwent a 8-weeks 
aerobic training (Azizi, 2011). This indicates that although the increase in serum leptin is 
indirect proportion with BMI in general, the major determinant of serum leptin level is 
the body fat as regular exercise reduces body fat rate, it also reduces serum leptin level. 
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In contrary, other studies revealed that both of short and long-term exercise did 
not affect leptin concentration (Weltman et al,. 2000; Kraemer et al., 2002). Weltman et 
al. (2000) reported that 30 minutes of exercise at, above and below lactate threshold (an 
index of accelerated metabolism and exercise intensity) did not alter leptin concentration 
in young males during exercise or recovery when compared with control values. The 
same finding has been observed by Zafeiridis et al. (2003) which recruited 10 young 
lean men to examine the effect of maximum strength, muscular hypertrophy and strength 
endurance resistance exercise protocols on serum leptin. There was no change in serum 
leptin concentration when sampled immediately after exercise or 30 minutes of 
recovery. 
 
2.3.3   Leptin and obesity 
Although leptin is a circulating signal that reduces appetite, in general, obese people 
have an unusual high circulating concentration of leptin. These peoples are found to be 
resistant to the effect of leptin, in much the same way that people with type 2 diabetes 
are resistant to the effect of insulin (Enriori et al., 2006; Myers et al., 2008). The loses 
ability of elevated leptin to suppress feeding and increased energy expenditure also 
known as leptin resistance (Myer et al., 2008). Leptin resistance can be promoted by a 
few mechanism including leptin-stimulated phosphorylation of Tyr985 on LRb and the 
suppressor of cytokine signaling 3 which attenuate leptin signaling (Myer et al., 2008). 
